Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA024200 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA024200, RRID:AB_1856730
- Product name
- Anti-SERPINB7
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SERPINB7, Gene description: serpin peptidase inhibitor, clade B (ovalbumin), member 7, Alternative Gene Names: MEGSIN, Validated applications: IHC, Uniprot ID: O75635, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references SerpinB7 deficiency contributes to development of psoriasis via calcium-mediated keratinocyte differentiation dysfunction
Acral peeling in Nagashima type palmo‐plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment
Mutations in SERPINB7, Encoding a Member of the Serine Protease Inhibitor Superfamily, Cause Nagashima-type Palmoplantar Keratosis
Zheng H, Gu L, Zhao F, Zhang C, Wang Z, Zhou H, Hu Z, Wei X, Liu X, Luo F, Zeng F, Zhao Q, Hao Y, Hu Y, Wang X, Hu J, Yu J, Wu W, Zhou Y, Zhou P, Yue C, Huang N, Cui K, Li W, Li J
Cell Death & Disease 2022;13(7)
Cell Death & Disease 2022;13(7)
Acral peeling in Nagashima type palmo‐plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion
Cohen‐Barak E, Azzam W, Koetsier J, Danial‐Farran N, Barcan M, Hriesh M, Khayat M, Edison N, Krausz J, Gafni‐Amsalem C, Kubo A, Godsel L, Ziv M, Allon‐Shalev S
Experimental Dermatology 2021;31(2):214-222
Experimental Dermatology 2021;31(2):214-222
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment
Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M, Fürnkranz K, Famler B, Schmeidl M, Minichsdorfer C, Zielinski C, Heller G, Prager G
Translational Oncology 2019;12(1):15-23
Translational Oncology 2019;12(1):15-23
Mutations in SERPINB7, Encoding a Member of the Serine Protease Inhibitor Superfamily, Cause Nagashima-type Palmoplantar Keratosis
Kubo A, Shiohama A, Sasaki T, Nakabayashi K, Kawasaki H, Atsugi T, Sato S, Shimizu A, Mikami S, Tanizaki H, Uchiyama M, Maeda T, Ito T, Sakabe J, Heike T, Okuyama T, Kosaki R, Kosaki K, Kudoh J, Hata K, Umezawa A, Tokura Y, Ishiko A, Niizeki H, Kabashima K, Mitsuhashi Y, Amagai M
The American Journal of Human Genetics 2013;93(5):945-956
The American Journal of Human Genetics 2013;93(5):945-956
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human skin and kidney tissues using Anti-SERPINB7 antibody. Corresponding SERPINB7 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
